Participants are randomly assigned, meaning the decision is made by chance, to receive either the lidocaine or the saline, and the trial is double‑blind so neither the care team nor the patients know which one is given. After the operation, pain is measured using a simple number scale from 0 (no pain) to 10 (worst pain) at several time points up to six months, along with questionnaires about daily activities and overall well‑being. The study follows each person for about half a year to see how the treatment affects long‑term pain and recovery.

The purpose of the study is to determine whether adding intra‑operative metamizole reduces the amount of opioid (a strong pain‑relieving drug often used after surgery) needed in the first few hours after surgery. Participants are randomly assigned to receive either the study drug or placebo, remain unaware of which they received, and have their pain levels recorded regularly. The primary measure is the total morphine (measured as milligram equivalents, a standard way to compare the strength of different opioid doses) consumed during and for three hours after the operation, with additional observations of rescue pain medication use, time to discharge, and overall pain scores up to 48 hours.

The aim is to find out whether the nasal dose of the study drug reduces the pain measured by the Premature Infant Pain Profile‑Revised during the first 30 seconds after the eye speculum is placed. Infants are randomly assigned to receive either the study drug or the placebo, then undergo the standard eye screening while pain scores and basic vital signs are recorded. After the exam the infants continue to be observed for a short period to monitor any breathing changes, oxygen needs, crying, sleep, or other reactions before returning to regular care.

Healthy volunteers will receive each of the three injections (the two anesthetics and the placebo) in separate study periods, with the order chosen at random and neither the participants nor the staff knowing which injection is given at any time. After each injection, a small device will apply electrical stimulation to create a temporary area of increased pain sensitivity called hyperalgesia, and participants will rate the pain they feel. Additional tests will use a cuff that inflates around the arm to measure the pressure at which pain is first felt and the pressure that can be tolerated, known as cuff-pressure algometry. Throughout the study, blood pressure, heart rate, any side effects and adverse events will be recorded, and each participation period lasts only a few days.

In the study, blood testing is done during a follow-up visit after the transplant. The tests are used to see how the platelets, which are small blood cells that help blood clot, respond to aspirin. The study looks at patients about 12 to 18 months after heart transplantation and compares the blood test results with health details such as age, sex, diabetes, high blood pressure, smoking, past rejection episodes, infections, and cholesterol levels.

The study does not use a new treatment. It focuses on testing the effect of the aspirin already being taken after heart transplantation. The results are intended to improve understanding of how well aspirin works in this setting.

The purpose of the study is to determine if adding dexamethasone can prolong the period during which a patient cannot feel sensations in specific areas of the body. The duration of the numbing effect is measured by how long it takes for the sensory block, or the loss of feeling, to decrease across certain areas of the skin. Additionally, the study monitors the time it takes for muscle movement to return to normal, known as the motor block recovery, and tracks any side effects or pain levels experienced after the surgery.

Participants in the study will be assigned to receive either the inhaled medicine or the injectable medicine. After the procedure is completed, the amount of brain tissue damage, known as cerebral infarction, will be measured. This measurement is performed using an MRI, which is a specialized imaging test that uses strong magnets to create detailed pictures of the inside of the body. The evaluation of the brain area affected by the stroke will take place approximately 72 hours after the treatment.

The investigation follows a specific design where participants receive different treatments in a set order to compare the results. Researchers will monitor various physical signs, such as the respiratory rate, which is the number of breaths taken per minute, and oxygen saturation, which measures the amount of oxygen in the blood. Other factors being observed include apnea, which is a temporary pause in breathing, and changes in pupil diameter. Additionally, participants will report their levels of alertness and how they feel regarding the effects of the substances used.

One group will receive esketamine hydrochloride in the form of a mouthwash, which is swallowed or used to rinse the mouth. The other group will receive esketamine through an intravenous infusion, which means the medicine is delivered directly into a vein. By comparing these two methods, researchers want to see if the mouthwash can provide similar pain relief to the liquid delivered through a vein.

During the study, participants will have their pain levels monitored to see how well each method works. Information will also be collected regarding side effects, the ability to eat or drink, and the amount of other pain medications needed during the treatment period. The researchers will also check the levels of the medication in the blood to understand how the body processes it through different methods.

The purpose of the study is to evaluate how the body processes the medication and to monitor its safety. Researchers will observe how the drug is absorbed into the bloodstream, how it moves throughout the body, and how it is eventually eliminated. Additionally, the study will track how the body reacts to the treatment to ensure it is safe for use in this age group.

Participants in the study will receive either lidocaine hydrochloride or sodium chloride through an intravenous infusion, meaning the substance is delivered directly into a vein. The study period covers the time around the surgery and the first 48 hours after the breathing tube is removed. Various factors such as pain levels, the amount of pain medication used, the length of time spent in the hospital, and the risk of other issues like pneumonia or acute kidney insufficiency will be observed during the recovery process.

Participants in the study involving the delivery system will receive these substances through a specialized pump. This approach involves intrathecal use, meaning the drugs are placed into the space between the membranes that cover the spinal cord to target pain more directly. During the course of the study, participants will be monitored to assess their quality of life, comfort levels, and how they manage the physical and emotional challenges of their condition.

During the study, infants will receive either dexmedetomidine or a placebo through an intravenous infusion, which means the medication is delivered directly into a vein. Participants will be assigned to one of these two groups by chance. The process involves monitoring the infants while they are receiving breathing support to see how the different treatments affect their need for pain medication and their overall comfort levels.

The purpose of this study is to investigate how long it takes and how well rapid sequence emergence from general anesthesia works, which means bringing someone quickly out of the sleep-like state caused by anesthesia. The study will measure several things during this process, with the main focus being on how long it takes for spontaneous breathing to return, meaning when the person starts breathing on their own again without help. Other measurements will include the time it takes for the person to open their eyes, when reflexes like swallowing and coughing come back, breathing patterns including oxygen levels and breathing rate, heart rate and blood pressure, brain activity levels, the depth of muscle relaxation, and the total time needed to become fully awake as before the anesthesia was given.

During the study, healthy volunteers will receive general anesthesia using the combination of medications mentioned above. The medications will be given through an injection into a vein. After the anesthesia is established, the reversal medications will be administered to bring the volunteers out of anesthesia in a controlled manner. Throughout this process, various measurements will be taken to track how quickly and smoothly the volunteers wake up from the anesthesia and return to their normal state.

The purpose of this study is to compare two different doses of enoxaparin to see which one works better at preventing major blood clots in people who have suffered severe injuries. Some patients will receive what is called an intermediate dose, which is a medium amount of the medication, while others will receive a standard dose, which is the usual amount doctors typically prescribe. Some patients will receive placebo. The study will look at whether patients develop serious blood clots such as deep vein thrombosis, which are clots that form in the deep veins of the legs, or pulmonary embolism, which are clots that travel to the lungs.

Patients in this study will receive injections under the skin of either the intermediate dose or standard dose of enoxaparin for up to 14 days while they are recovering from their injuries. During this time, doctors will carefully monitor patients for any signs of blood clots or bleeding problems. The study will also track whether patients experience any major bleeding, since blood-thinning medications can sometimes increase the risk of bleeding. All participants will be followed for 30 days after starting the treatment to see how well they recover and whether they develop any complications related to blood clots or bleeding.

The purpose of this study is to find out how different doses of dexamethasone affect quality of life for patients in the three months after hip replacement surgery. Quality of life refers to how well a person feels in their daily activities, including their physical comfort, ability to move around, and overall well-being. The study will compare the effects of the lower dose against the higher dose to see which one works better for helping patients recover and feel better after their surgery.

During the study, patients will receive one of the two doses of dexamethasone during their hip replacement operation. After the surgery, patients will be asked to complete questionnaires at different time points to measure how they are feeling and recovering. These questionnaires will ask about their quality of life, recovery progress, hip function, pain levels, and tiredness at various times following the surgery, including on days 1, 3, and 5, as well as at 30, 60, and 90 days after the operation. The study will help doctors understand which dose of dexamethasone might be more helpful for patients recovering from hip replacement surgery.

Patients in this study will be randomly assigned to receive either the spinal morphine injection or the epidural pain relief method. Both groups will also receive additional pain medications as needed to keep them comfortable. The study will measure how well patients are recovering using a questionnaire that asks about their overall well-being and recovery quality. This will be checked on the second day after surgery and at several other times up to one year after the operation. The study will also track pain levels, patient satisfaction with pain control, how quickly patients can move around and return to normal activities, how long they stay in the hospital, and whether they experience any unwanted effects from the treatments.

Throughout the study, various aspects of recovery will be monitored, including how much additional pain medication patients need, whether they experience side effects such as nausea, itching, drowsiness, or breathing problems, and how quickly their bowel function returns to normal. The study will also look at overall health-related quality of life, any confusion after surgery, and whether patients develop any complications. For patients who have cancer, the study will track when they are able to start chemotherapy treatment if needed. All of these measurements help researchers understand which pain control method allows for better recovery after colorectal surgery.

The purpose of the study is to find out whether a lower dose or a medium dose of dexamethasone given through an intravenous injection, which means directly into a vein, is more effective at reducing the occurrence of rebound pain after foot surgery. Patients in this study will undergo open orthopedic foot surgery, which is a type of surgery where the surgeon makes an incision to access and repair structures in the foot. The surgery will be performed on an outpatient basis, meaning patients can go home the same day rather than staying overnight in the hospital. All patients will receive the nerve block for pain control during surgery, and they will also receive one of the two doses of dexamethasone to help prevent severe pain from returning suddenly when the nerve block wears off.

During the study, patients will have their pain levels checked at specific times after surgery through telephone calls at 24 hours, 48 hours, and 72 hours following the procedure. Pain will be measured using a scale where zero means no pain and ten means the worst pain imaginable. The study will track when patients first feel pain at the surgical site after the nerve block stops working, and will also monitor for any unwanted effects related to the medication, such as high blood sugar levels measured before patients leave the hospital, or problems with wound healing that might occur up to one month after surgery.

The purpose of the study is to compare how well patients recover within 24 hours after surgery when they receive pain relief with either tramadol or morphine as part of a combination approach to managing pain. Recovery will be measured using a questionnaire that asks about different aspects of how patients are feeling. Both morphine and tramadol are types of pain medications called opioids that work by affecting how the brain and body sense pain. Patients in the study will receive one of these medications during and after their surgery as part of their pain management plan.

During the study, patients will be asked to complete questionnaires at different times after surgery to assess their recovery and pain levels. The study will track how much pain medication is needed, how long patients stay in the recovery area and in the hospital, and whether any side effects occur such as nausea, vomiting, itching, or confusion. Patients will also be contacted at one month and three months after leaving the hospital to ask about ongoing pain medication use and whether they have developed long-lasting pain from the surgery. The study will look at satisfaction with pain management and assess the risk of medication misuse using specific evaluation tools.

During the study, patients will receive either music therapy or midazolam before their scheduled surgery. The researchers will measure anxiety levels using different methods. They will use brain wave monitoring called electroencephalogram, which is a way to record electrical activity in the brain using sensors placed on the head. This monitoring is done with a device called Bispectral Index monitoring, which helps measure how alert or calm a person is. The researchers will also ask patients to complete questionnaires that measure anxiety levels. Additionally, they will check other body measurements such as blood pressure, heart rate, and oxygen levels in the blood.

The study will track patients who are scheduled for different types of surgery, including those who will go home the same day and those who will stay in the hospital. The researchers will collect information about the type of surgery each patient is having and will watch for any unwanted effects. They will also note if patients are taking any regular medications. The information gathered will help doctors understand which method of reducing anxiety before surgery might work better and last longer for patients.

Participants in this study will be adults who are scheduled to have either weight loss surgery or gallbladder removal surgery performed using keyhole techniques under general anesthesia. Before the surgery, participants will be asked about their overall health and wellbeing. During the operation, they will receive either the study medications or the comparison medication through a vein. After the surgery, participants will be asked to complete questionnaires about how they are feeling, including questions about nausea, vomiting, pain, and their overall recovery. These questions will be asked on the day of surgery and for the following three days while they are in hospital and at home.

The study will also track how much pain medication and anti-sickness medication participants need to use, how long they stay in the recovery area and in hospital, and whether they experience any side effects from the medications such as reactions at the injection site, headache, vision changes, constipation, diarrhea, or tiredness. Any complications that occur up to thirty days after surgery will be recorded. Some participants will also be invited to take part in interviews between one and three months after their surgery to talk about their experience of recovering from the operation.

The purpose of this study is to find out whether giving freeze-dried plasma early in the emergency room works better than giving the standard salt solution to patients in hemorrhagic shock. The researchers believe that the freeze-dried plasma might help patients recover faster because it can be prepared and given much more quickly than regular plasma, it may help protect the blood vessels, and it stays in the bloodstream longer. They will measure how quickly patients improve by checking the level of a substance called lactate in the blood, which goes up when the body is not getting enough oxygen. The study will also look at whether using freeze-dried plasma means that patients need less of the salt solution, which could help avoid problems that sometimes happen when too much fluid is given.

During the study, patients who come to the emergency room with hemorrhagic shock will receive either the freeze-dried plasma or the standard salt solution through an infusion into their vein. The doctors will monitor how the patients respond to the treatment and will measure various signs of recovery. The study will compare the two treatments to see which one helps patients stabilize more quickly and which one leads to better outcomes overall.

Women taking part in the study will be divided into two groups. One group will receive sufentanil before the procedure, while the other group will receive the standard treatment with midazolam. During the egg collection procedure, pain levels will be measured every two minutes using a pain scale where participants mark their pain level on a line. The study will also look at how satisfied participants are with their pain management about one day after the procedure, how much pain they feel in the recovery area and at home, whether they need to take additional pain medication at home, and whether they experience side effects such as nausea, vomiting, or breathing problems.

After the procedure, participants will be monitored in a recovery area before going home. They will be contacted about one day later to answer questions about their pain, satisfaction with pain management, any side effects, and any additional pain medication they took at home. The study will also collect information about the procedure itself, such as how long it took, how many eggs were collected, and certain hormone levels measured before and after the procedure. Information about whether pregnancy occurs will also be collected.

During the study, patients will receive one of the three medications to make them unconscious before the breathing tube is placed. The medical team will measure how successfully the breathing tube can be placed on the first attempt, which is the main goal of the study. They will also look at several other things during and after the procedure, including how easy it is to place the breathing tube, how long it takes to complete different steps of the process, and measurements of heart rate, blood pressure, and oxygen levels in the blood during the first five minutes after the medication is given. The team will check for any problems such as stomach contents moving into the lungs, low oxygen levels, changes in blood pressure or heart rate that require treatment, allergic reactions, and whether additional medications or fluids are needed.

After the procedure, patients will be monitored in the recovery room where the medical team will check for confusion or agitation and whether any calming medication is needed. For up to seven days after surgery, the study will track whether patients develop heart problems, kidney problems, or other serious complications, as well as survival rates. The study will help doctors understand whether remimazolam is as safe and effective as the other two medications currently used for this type of procedure.

The purpose of the study is to find out whether lidocaine given through a vein can lower the levels of a substance called interleukin-6 in the blood six hours after surgery ends. Interleukin-6 is a marker of inflammation in the body, and high levels of it are associated with the inflammatory response caused by the heart-lung machine. The study will also measure other markers of inflammation and heart stress, including C-reactive protein, high-sensitivity Troponin T, and TNF-α, at different times before, during, and after surgery. Additionally, the study will look at whether patients who receive lidocaine have fewer complications after surgery, spend less time in the intensive care unit, have better survival rates one month after surgery, and experience less pain in the days following the operation.

Patients in the study will be randomly assigned to receive either lidocaine or placebo during their surgery and for a period afterward. Neither the patients nor the doctors will know which treatment is being given, which helps ensure fair and accurate results. Blood samples will be taken at specific times to measure the inflammation markers, and information about any complications, length of stay in the intensive care unit, heart rhythm problems after the heart is restarted, pain levels, and need for pain medication will be collected. The study is expected to begin enrolling patients in October 2025 and continue until April 2027.

The purpose of the study is to find out if the spine block method is effective in reducing pain for patients with kidney stones, and whether it can improve patient satisfaction and reduce the need for hospital stays or additional procedures. The study will also look at whether this treatment can lower the amount of additional pain medication needed and reduce side effects from pain medications. After the initial treatment in the emergency department, patients will be asked about their pain levels at different times over the first 24 hours, and then again at seven days and one month later. The study will measure pain intensity, how much the pain interferes with daily activities, quality of life, and whether patients need to return to the emergency department or require surgery for their kidney stones.

During the study, patients will complete questionnaires about their pain, how it affects their daily activities, their overall well-being, and their satisfaction with the treatment. The study will track whether patients need to be admitted to the hospital, whether they require procedures to remove or break up the stones, and how much additional pain medication they use. The study will also monitor for any complications related to the treatment and will assess whether patients develop ongoing pain problems one month after receiving the treatment. Information about healthcare costs and time away from work will also be collected to understand the overall impact of the treatment.

The purpose of this study is to find out if the erector spinae plane block is effective in helping patients with non-specific low back pain by reducing their pain and allowing them to move around more easily right away. The study will look at whether this treatment can decrease pain by half and improve the ability to walk within thirty minutes after the procedure is performed.

During the study, patients will undergo the procedure and then be followed for six months. Pain levels will be measured at various times, starting from thirty minutes after the procedure and continuing through the follow-up period. The study will track how well patients can move, how much pain medication they need to take, how many steps they can walk each day in the first few days, and how well they sleep during the first three days. Patients will complete questionnaires at different time points to assess their pain, physical function, quality of life, and any side effects from the pain medications. Information will also be collected about medical visits, physical therapy sessions, any return of back pain, and when patients are able to return to work during the six-month follow-up period.

The purpose of the study is to compare the dose of sugammadex that works in adults with the dose needed in children under 24 months of age. Doctors will measure muscle function using a special monitoring device that checks how well the muscles are working. They will give small repeated doses of sugammadex, each dose being 0.2 milligrams per kilogram of body weight, until the muscle function returns to normal. This is different from the usual practice where doctors give one single larger dose.

During the study, doctors will carefully watch how the child’s muscles respond after each dose of sugammadex is given. They will record the total amount of medicine needed to achieve complete muscle recovery and check whether the dose is lower or higher than what is typically used in adults. The medical team will also monitor for any problems such as the muscle relaxation coming back after it was reversed, any breathing difficulties, or allergic reactions to the medicine. The study will track these measurements for up to 60 minutes after the last dose of sugammadex is given.

Patients participating in this study will have experienced persistent headaches for at least 24 hours despite receiving conservative treatment such as rest, fluids, and pain medication. They will receive either the sphenopalatine block or the blood patch procedure. After the treatment, headache intensity will be measured using a scale from zero to ten, where zero means no pain and ten represents the worst possible pain. These measurements will be taken at multiple time points: at the start of the procedure, then at 30 minutes, one hour, two hours, six hours, 24 hours, 48 hours, and seven days after treatment. The treatment period lasts one day, with follow-up assessments continuing for seven days.

The study will also track several other aspects of patient care and recovery. This includes monitoring how much pain medication patients need after the procedure, whether additional treatment with a blood patch becomes necessary, and how long patients need to stay in the hospital during the seven-day period following treatment. Any unwanted effects that occur during the procedure will be recorded, as well as any serious complications. Patient satisfaction with the treatment will be assessed seven days after the procedure using a rating scale. The study aims to determine whether the sphenopalatine block offers a comparable alternative to the blood patch for managing this painful condition.

During the study, patients will be prepared for surgery that requires a breathing tube. They will receive oxygen before the procedure begins. Then they will be given medications to put them to sleep and relax their muscles. The muscle relaxing medication will be given in a dose that is calculated either based on what the patient should ideally weigh or based on what they actually weigh. The doctor will then place the breathing tube and evaluate how easy or difficult it was to do this. The time it takes to place the tube will be measured, and the level of muscle relaxation will be checked. The oxygen levels in the blood will be monitored throughout the procedure.

The study will look at whether excellent conditions for placing the breathing tube are achieved with either dosing method. It will also examine how many patients have acceptable conditions for tube placement, how long it takes to successfully place the tube, and whether any extra techniques are needed to get a better view of the airway. The study will record oxygen levels at different times during the procedure and track any problems that occur, such as drops in oxygen levels or changes in blood pressure. The study is expected to begin enrolling patients in October 2025 and continue until the end of 2028.

During the study, patients will receive one of the treatments before their eye surgery. The study will measure pain and anxiety levels at different times: when patients first arrive, before the numbing injection is given, right after the injection is given, and immediately after the surgery is completed. Pain will be measured using a scale where patients rate their pain level, and anxiety will be measured using questionnaires that ask about feelings of nervousness or worry. The study will also record how long it takes to give the numbing injection behind the eye.

Patients participating in this study will be adults over 18 years old who need surgery on one eye only. The treatments being tested are taken by mouth in tablet form. The study aims to understand whether these approaches can make the surgical experience less painful and less stressful for patients undergoing this type of eye surgery with retrobulbar anaesthesia.

The purpose of the study is to find out how well intranasal dexmedetomidine works for sedating children during imaging procedures. The study will look at whether one dose of the medication is enough to provide adequate sedation, or whether some children need a second dose. The researchers will measure how quickly the sedation begins after giving the medication and how long the sedation lasts. They will also track how long the imaging procedure takes, how long children wait before the procedure starts, and how long the total hospital visit lasts.

During the study, the medication will be given through the nose before the imaging procedure begins. The medical team will watch the children carefully to see how well the sedation works and to check for any unwanted effects. The study will also record any side effects that occur. All children participating will receive the active medication, as this study does not include a placebo group. The information gathered will help doctors understand whether this method of giving dexmedetomidine is a good option for sedating children during imaging procedures.

Children in the study will be between one month and seventeen and a half years old and will need to be on a breathing machine for more than twelve hours. They will receive one of the two sedation medications as their main treatment to keep them comfortable. Throughout their stay in the intensive care unit, doctors and nurses will regularly check for signs of delirium using a special rating scale. They will also monitor how well the sedation is working, whether the child is too sleepy or not sleepy enough, and any side effects that might occur. The study will track how long children need to stay on the breathing machine, how long they stay in the intensive care unit, and how long they remain in the hospital overall.

The study will also look at other important outcomes, including how much sedation and pain medication each child needs, whether children experience withdrawal symptoms when medications are stopped, and whether any complications occur such as low blood pressure, slow heart rate, or accidental removal of breathing tubes or other medical devices. Doctors will record if children need additional medications to treat delirium, if they need brain imaging or special tests to check brain activity, and whether they need to be put back on the breathing machine after it is removed. The study will continue to follow children for three months to understand the full impact of the different sedation approaches on their recovery and the costs of their care.

The research will analyze blood samples from patients who are receiving antibiotics as part of their normal treatment in the intensive care unit. The main goal is to determine if current antibiotic dosing practices achieve the right levels of medication in the blood to effectively treat infections in critically ill patients.

The study will track antibiotic concentrations in the blood and monitor treatment outcomes, including how well the infection responds to treatment and any side effects that may occur. This information will help improve understanding of how antibiotics work in critically ill patients and may lead to better dosing recommendations for future treatment.

The main purpose of this study is to determine how well the lower concentration of medication works in providing pain relief compared to the standard higher concentration. During the study, other medications may also be used as needed, including fentanyl for additional pain relief and ropivacaine as an alternative local anesthetic. The effectiveness of the pain relief will be measured at various times during labor.

Throughout labor, healthcare providers will monitor the mother’s pain levels, ability to move, and overall comfort. They will also track how the different medication concentrations might affect the delivery process and the newborn’s health. The study will evaluate patient satisfaction with the pain relief method and record any complications that may occur during or after the procedure.

The study uses two medications: ropivacaine hydrochloride (a local anesthetic that numbs specific areas) and sodium chloride solution (salt water). Some patients will receive the pain-blocking medication, while others will receive placebo. The purpose is to determine if this nerve-blocking technique can improve recovery after heart surgery.

During the study, patients will receive injections on both sides of their chest after surgery. Their recovery will be monitored through various assessments, including pain levels and overall well-being. The research team will evaluate how well patients recover in the first few days after surgery and follow up with them for one month to assess their healing progress.

The medications used in this study include ropivacaine, a local anesthetic that helps control pain, and epinephrine, a medication that helps reduce bleeding. Both medications will be given as injections near the surgical area. The purpose of this research is to determine which of these two methods is more effective in reducing blood loss and controlling pain after spine surgery.

During the study, patients undergoing lumbar fusion surgery will receive either the PIV or ESP treatment. The medical team will monitor the amount of blood loss during surgery and track how well pain is controlled afterward. This research aims to help doctors better understand which method provides better results for patients having this type of back surgery.

The purpose of this research is to determine if adding sodium bicarbonate to the anesthetic solution affects how well patients recover shortly after their surgery. During the study, patients will receive one of these anesthetic solutions before their operation. The surgery will be performed while the patient is awake, using local anesthesia without the need for general anesthesia or sedation.

The study will track various aspects of recovery, including comfort levels after surgery, how quickly the anesthetic takes effect, and how long the numbness lasts. Patients will be asked about their pain levels and overall satisfaction with the procedure. The research team will also monitor for any complications that might occur after surgery.

The study aims to compare different methods of sedation and pain control in critically ill patients who need both deep sedation and muscle relaxation. These patients are typically those with severe conditions requiring breathing support through mechanical ventilation, increased pressure in the brain, or continuous seizures. The study will monitor how different combinations of medications and monitoring methods affect the amount of pain medication needed.

During the study, patients will receive either intravenous sedation medications or inhaled sedation, along with pain medications. Some patients will have their pain levels monitored using a special device called NOL (Nociception Level) monitor, while others will receive standard care without this monitoring. The study will track various aspects of patient care, including breathing status, heart function, brain monitoring, and the development of any infections.

The purpose of this research is to determine which medication provides better and safer conditions for placing the breathing tube in adult patients who need tracheal intubation during surgery. The study will look at how well each medication works and any possible side effects that may occur during or after the procedure.

During the study, patients will receive either remifentanil or rocuronium before the breathing tube is inserted. Doctors will monitor patients for any complications that might occur within 24 hours after the procedure, including effects on breathing, heart function, or discomfort in the throat. The medication doses are carefully calculated based on each patient’s weight, with remifentanil given at up to 4 micrograms per kilogram and rocuronium at up to 0.6 milligrams per kilogram.